Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by rgonlyfactsplson Aug 11, 2015 5:53pm
174 Views
Post# 24008717

Bioengineered Bladder Tissue—Close but Yet So Far!

Bioengineered Bladder Tissue—Close but Yet So Far!I guess title says it all --- The Journal of Urology.... September 2015 Volume 194, Issue 3, Pages 619620 --- Bioengineered Bladder TissueClose but Yet So Far! --- https://www.jurology.com/article/S0022-5347(15)04152-X/abstract?elsca1=etoc&elsca2=email&elsca3=0022-5347_201509_194_3_&elsca4=Urology --- Department of Urology, University of California-Davis Medical Center, Sacramento, California --- Current clinical strategies to augment or reconstruct dysfunctional bladders rely on the use of intestine as a tissue substitute. Although this has been the standard protocol for decades, bladder augmentation with gastrointestinal tissue is fraught with short-term and long-term complications. In response to the need for a better bladder tissue substitute urological researchers have turned to tissue engineering strategies. While certain aspects of bladder tissue engineering have elevated the promise of this technology, the lack of success in a recent pediatric clinical trial of bladder augmentation using engineered bladder grafts highlights the gaps between theory and practice that still exist.
<< Previous
Bullboard Posts
Next >>